COVID-19 Ab Rapid Test
- UID
- MFG/IVD/2020/000034_e87d197c71df90fb1babb8e773134f8b_1d9fe7b11309c2618b00d879a4ede860
- Device class
- Class C
- Brand name
- Aridia
- License holder
- Athenese-Dx Private Limited
- Approving authority
- Central Drug Standard Control Organisation, South Zone
- Product information
- The TRUSTline COVID-19 Ab Rapid Test is a single use lateral flow immunoassay rapid test intended for qualitative detection of anti-SARS-CoV-2 antibodies in human serum and plasma or whole blood containing EDTA, heparin or citrate anti-coagulants. The TRUSTline COVID-19 Ab Rapid Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2 infection
COVID-19 Ab Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000034_e87d197c71df90fb1babb8e773134f8b_1d9fe7b11309c2618b00d879a4ede860. This device is marketed under the brand name Aridia. The license holder is Athenese-Dx Private Limited, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.